Point Of Care Diagnostics Market size worth $ 59.20 Billion, Globally, by 2030 at 9.83% CAGR: Verified Market Research®

News provided by

Aug 23, 2022, 09:15 ET

An increase in the number of chronic and infectious diseases has led to an increase in the number of medical tests, the rise in the number of pathology labs equipped with advanced diagnostic equipment, has lead the market growth.

JERSEY CITY, N.J., Aug. 23, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Point Of Care Diagnostics Market" By Product (Glucose Monitoring, Infectious Disease Testing), By End Use (Hospitals, Homecare), and By Geography. According to Verified Market Research, the Point Of Care Diagnostics Market size was valued at USD 28.47 Billion in 2021 and is projected to reach USD 59.20 Billion by 2030, growing at a CAGR of 9.83% from 2022 to 2030.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=28454

Browse in-depth TOC on "Point Of Care Diagnostics Market"

202 - Pages
126 – Tables
37 – Figures

Global Point Of Care Diagnostics Market Overview

Point of Care Diagnostics is becoming increasingly popular. Convenience, reduced patient wait times, fewer or no follow-ups, accurate test findings, rapid patient management, and improved healthcare delivery are all expected to drive the market. In the US, the number of patients receiving treatment for acute and chronic diseases at home is increasing and this is expected to increase demand for Point of Care Diagnostics devices, and thus, the market. About 10,000 older people turn 65 every day in the United States, most of whom want to grow older in their own homes. This is expected to increase demand for Point of Care Diagnostics devices for use at home. Increasing investments in the field of Point of Care Diagnostics are also expected to boost the market. For instance, in May 2021, AAD, a developer of rapid diagnostic and data systems, announced a USD 7M investment for Point of Care Diagnostics in animal and human health.

In April 2021, FIND, the global alliance for diagnostics, announced an investment of USD 21 million in Biomeme, Bioneer, Qlife, and SD Biosensor, to accelerate the development, manufacturing, and launch of affordable point-of-care molecular diagnostic platforms that can detect multiple pathogens that cause diseases including COVID-19, in low- and middle-income countries. In November 2021, the US Department of Health and Human Services announced an investment of USD 650 million from the American Rescue Plan to increase rapid molecular point-of-care diagnostic tests for SARS-CoV-2. Globally, over 37.7 million individuals were living with HIV in 2020, according to the United Nations Program on HIV/AIDS. This is expected to increase demand for Point-of-care testing.

Key Developments

In Apr 2022, Trinity Biotech plc, a global diagnostics leader, announced a $45 million strategic investment and cooperation with MiCo Ltd ("MiCo"). MiCo, a KOSDAQ-listed company established in Korea, is involved in the biomedical business through its affiliate MiCo BioMed, as well as delivering cutting-edge technology-driven solutions.
In June 2021, Danaher Corporation (NYSE: DHR) (the "Company") stated that it has entered into a formal agreement to buy privately held Aldevron for approximately $9.6 billion in cash. Danaher anticipates financing the transaction with cash on hand and/or revenues from commercial paper issues.

Key Players

The major players in the market are Danaher Corporation, Trinity Biotech, Abbott Laboratories, Roche Diagnostics, Accubiotech, EKF Diagnostics.

Verified Market Research has segmented the Global Point Of Care Diagnostics Market On the basis of Product, End Use, and Geography.

Point Of Care Diagnostics Market, By Product

Glucose Monitoring
Infectious Disease Testing
Cardio Metabolic Monitoring
Others

Point Of Care Diagnostics Market, By End Use

Hospitals
Homecare
Decentralized Labs
Others

Point Of Care Diagnostics Market, by Geography

North America

U.S
Canada
Mexico

Europe

Germany
France
U.K
Rest of Europe

Asia Pacific

China
Japan
India
Rest of Asia Pacific

ROW

Middle East & Africa
Latin America

Browse Related Reports:

Cardiac Biomarkers Testing Market By Type (Troponin, Creatine kinase-muscle/brain (CK-MB)), By Application (Myocardial Infarction, Congestive Heart Failure), By Testing Location (Point of Care Testing, Laboratory Testing), By Geography, Forecast, 2021-2028

Biosensors Market By Type (Embedded Device and Sensor Patch), By Product (Wearable Biosensor and Non-Wearable Biosensor), By Technology (Electrochemical Biosensor, Optical Biosensor, Piezoelectric Biosensor), By Application (Point of Care, Home Diagnostics, Research Lab), By Geography, Forecast, 2021-2028

Point Of Care Blood Gas And Electrolyte Market By Type (Consumables, Instruments), By End-User (Hospitals And Clinics, Home Care), By Geography, Forecast, 2021-2028

Point of Care Diagnostic Devices Market By Product (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing), By Application (Clinics, Hospitals, Laboratory), By Geography, Forecast, 2021-2028

Top 10 Point-Of-Care Diagnostics Companies pushing latent capacity for patients' recuperation

Visualize Point Of Care Diagnostics Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: [email protected]
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

SOURCE Verified Market Research